Ontuxizumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Chimeric/humanized hybrid (mouse/human) |
| Target | TEM1 |
| Identifiers | |
| CAS Number | 946415-62-9 |
| ATC code | none |
| Chemical data | |
| Formula | C6532H10050N1726O2054S44 |
| Molecular mass | 147.0 kg/mol |
Ontuxizumab[1] is a monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1).[2]
This drug was developed by Morphotek.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Monoclonal antibodies
- Monoclonal antibody stubs
